 |
 |
|
| |||||||||||||||||||||||||||||||||||||||||||
15 February 2005 | Volume 142 Issue 4 | Pages 289-298
Celiac disease is a common autoimmune disorder that has genetic, environmental, and immunologic components. It is characterized by an immune response to ingested wheat gluten and related proteins of rye and barley that leads to inflammation, villous atrophy, and crypt hyperplasia in the intestine. The disease is closely associated with genes that code for human leukocyte antigens DQ2 and DQ8. Transglutaminase 2 appears to be an important component of the disease, both as a deamidating enzyme that can enhance the immunostimulatory effect of gluten and as a target autoantigen in the immune response. Sensitive and specific serologic tests, including those for anti–transglutaminase antibody, are facilitating fast and noninvasive screening for celiac disease. Thus, they are contributing to a more accurate estimate of the prevalence of the disease and its association with other disorders. Celiac disease is associated with increased rates of anemia, osteoporosis, cancer, neurologic deficits, and additional autoimmune disorders. A gluten-free diet is the mainstay of safe and effective treatment of celiac disease, although its effect on some of the extraintestinal manifestations of the disease remains to be determined.
Author and Article Information
From Cornell University and Columbia University, New York, New York.
Requests for Single Reprints: Armin Alaedini, PhD, Department of Neurology and Neuroscience, LC-807, Cornell University, 1300 York Avenue, New York, NY 10021; e-mail, ara2004{at}med.cornell.edu.
Potential Financial Conflicts of Interest: Consultancies and Honoraria: P.H.R. Green (Prometheus Laboratory).
Current Author Addresses: Dr. Alaedini: Department of Neurology and Neuroscience, LC-807, Cornell University, 1300 York Avenue, New York, NY 10021.
Dr. Green: Department of Medicine, Room 645, Columbia University, 161 Fort Washington Avenue, New York, NY 10032. REVIEW
Narrative Review: Celiac Disease: Understanding a Complex Autoimmune Disorder
This article has been cited by other articles:
|
|
 |
|
  L. Pastore, G. Campisi, D. Compilato, and L. L. Muzio Orally Based Diagnosis of Celiac Disease: Current Perspectives Journal of Dental Research, December 1, 2008; 87(12): 1100 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Alaedini, H. Okamoto, C. Briani, K. Wollenberg, H. A. Shill, K. O. Bushara, H. W. Sander, P. H. R. Green, M. Hallett, and N. Latov Immune Cross-Reactivity in Celiac Disease: Anti-Gliadin Antibodies Bind to Neuronal Synapsin I J. Immunol., May 15, 2007; 178(10): 6590 - 6595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Basso, G Guariso, P Fogar, F Navaglia, C-F Zambon, and M Plebani Insights in the Laboratory Diagnosis of Celiac Disease Lupus, July 1, 2006; 15(7): 462 - 465. [Abstract] [PDF]
|
|
|
|
 |
|
 M. L. Bianchi and M. T. Bardella Celiac Disease: Its Effects on Bone IBMS BoneKEy, May 1, 2006; 3(5): 30 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M I Torres, M A Lopez-Casado, J Luque, J Pena, and A Rios New advances in coeliac disease: serum and intestinal expression of HLA-G Int. Immunol., May 1, 2006; 18(5): 713 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zintzaras and A. E. Germenis Performance of Antibodies against Tissue Transglutaminase for the Diagnosis of Celiac Disease: Meta-Analysis Clin. Vaccine Immunol., February 1, 2006; 13(2): 187 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Knip, R. Veijola, S. M. Virtanen, H. Hyoty, O. Vaarala, and H. K. Akerblom Environmental Triggers and Determinants of Type 1 Diabetes Diabetes, December 1, 2005; 54(suppl_2): S125 - S136. [Abstract] [Full Text] [PDF]
|
|
Read all Rapid Responses
Article
